JPRN-UMIN000035961已完成未知
Randomized controlled trial on immunomodulatory Effects of Azithromycin in Children with Steroid Dependent Nephrotic Syndrome - Immunomodulatory effect of azithromycin on SDNS
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 57
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 1years-old 至 10years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •- Patients have received immunosuppressive or cytotoxic drugs other than steroids. - Patients with impaired liver functions, or with baseline risk of cardiovascular disease (i.e. prolonged QT syndrome, abnormally slow heart rate, congenital or acquired cardiac diseases or low levels of potassium and magnesium) - Secondary nephrotic syndrome
研究者
相似试验
尚未招募
2 期
Immunomodulatory action of Balchaturbhadra Syrup in Lowering Down Morbidity in childreCTRI/2022/09/045142niversity Post Graduate Institute of Ayurved Studies and Research DSRRAU Jodhpur
已完成
不适用
A randomized controlled trial of immune-enhancing enteral feeding on immunologic and nutritional status in tube-fed patientsmalnutritionJPRN-UMIN000001326Morinaga Milk Industry Co., Ltd.126
进行中（未招募）
1 期
Randomized and controlled clinical trial of the efficacy and safety of the use of lidocaine and magnesium sulfate for lung resection surgery using Video-Assisted Thoracic Surgery (VATS)CTIS2023-509503-33-00Clinica Universidad De Navarra128
招募中
1 期
A study to assess the efficacy of a cardiac drug and a anti-inflammatory drug in patients with post-acute inflammatory heart disease due to COVID-19Inflammatory cardiovascular involvement due to COVID-19, defined by Cardiovascular magnetic resonance imagingMedDRA version: 23.0Level: PTClassification code 10084268Term: COVID-19System Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.0Level: LLTClassification code 10007650Term: Cardiovascular disorder NOSSystem Organ Class: 10007541 - Cardiac disordersEUCTR2022-001682-12-ATGoethe University Frankfurt280
招募中
3 期
A Randomized Controlled Trial Of An Immunomodulator Mycobacterium w In Mild To Moderate Covid-19 PneumoniaCTRI/2020/08/027475Cadila Pharmaceuticals Limited